Investment Director @ Innovacorp (April 2014 - May 2022)
Chief Executive Officer @ Performance Genomics Inc. (February 2012 - December 2013)
Owner @ BlueBio Green Solutions (April 2007 - September 2012)
CEO @ Genome Atlantic (January 2003 - December 2007)
CEO @ SignalGene Inc. (January 1999 - December 2002)
CEO @ BioSignal Inc (January 1991 - December 1999)
Research Associate @ (January 1987 - January 1991)
Michael Dennis Education
Pasteur Institute
Post-Doc (Protein Chemistry)
1984-1987
Université de Montréal
Ph.D. (Biochemistry)
1978-1985
Clinical Research Institute of Montreal
Ph.D. (Neuro endocrinologie)
1978-1984
Dalhousie University
B.Sc., M.Sc. (Biochemistry)
1972-1978
Michael Dennis Skills
Drug Discovery
Biochemistry
Biotechnology
Genomics
High Throughput Screening
DNA
Lifesciences
Molecular Biology
Entrepreneurship
Plant Breeding
Biopharmaceuticals
Cell Biology
Science
Cell
Pharmacology
Technology Transfer
R&D
Commercialization
Leadership
PowerPoint
Investments
Life Sciences
Program Management
Customer Service
Michael Dennis Summary
Michael Dennis, based in Canada, is currently a VP Research at pHathom Technologies, Inc. Michael Dennis brings experience from previous roles at Earth Tech 2050, Last40 Ventures, Rimot.io and Innovacorp. Michael Dennis holds a 1984 - 1987 Post-Doc in Protein Chemistry @ Pasteur Institute. With a robust skill set that includes Drug Discovery, Biochemistry, Biotechnology, Genomics, High Throughput Screening and more. Michael Dennis has 1 mobile phone numbers on RocketReach.
Looking for a different Michael Dennis?
Find contact details for 700 million professionals.